Join us for an in-depth review of the latest updates to GVP Module XVI, with a focus on Risk Minimization Measures (aRMMs). This webinar will provide critical insights for Marketing Authorization Holders and applicants, covering the role of risk minimization in risk management planning and its impact on the risk-benefit balance of medicinal products. We will also explore methods for evaluating the effectiveness of these measures.
Agenda
Relevant updates to Module XVI – Risk minimization measures (Rev 3).
Updates to Module XVI Addendum II – Methods for evaluating effectiveness of risk minimization measures.
Q & A
Price
Free
Language
English
OPEN TO
Everyone
Dial-in Number
Please register for this Webinar to view the dial-in info.